"Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania"

PHASE4CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

July 27, 2017

Primary Completion Date

December 28, 2017

Study Completion Date

February 17, 2018

Conditions
Malaria,Falciparum
Interventions
DRUG

Artemether-Lumefantrine Tab 20-120mg

Artemether-Lumefantrine Tablet 20-120mg

DRUG

Primaquine Phosphate 0.25 mg/kg

Primaquine Phosphate 0.25 mg/kg

OTHER

Placebo

Aqueous solution prepared to mimic the taste of the intervention drug.

Trial Locations (2)

+255

Fukayosi Dispensary, Bagamoyo

Yombo Dispensary, Bagamoyo

All Listed Sponsors
collaborator

Uppsala University

OTHER

collaborator

Karolinska Institutet

OTHER

collaborator

The University of Western Australia

OTHER

lead

Muhimbili University of Health and Allied Sciences

OTHER

NCT03241901 - "Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania" | Biotech Hunter | Biotech Hunter